Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism

Patients with chronic kidney disease often develop secondary hyperparathyroidism (SHPT), marked by high levels of circulating parathyroid hormone (PTH) and increased risk of morbidity and mortality. Patients with SHPT are treated with a therapeutic combination that commonly includes calcimimetics, w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Apher Dial
Asıl Yazarlar: Akizawa, Tadao, Ikejiri, Kazuaki, Kondo, Yuichiro, Endo, Yuichi, Fukagawa, Masafumi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons Australia, Ltd 2019
Konular:
Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7317959/
https://ncbi.nlm.nih.gov/pubmed/31486206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1744-9987.13434
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller